GlassScriptPhysician profile
Amy Moreno
NPI 1235175332
$1,532.07
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $800 · 2020: $214 · 2021: $492 · 2022: $26.74.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $500.56 | 2019-2021 | |
| Astellas Pharma US INC | $354.68 | 2019-2021 | |
| Axonics, INC. | $137.35 | 2020-2021 | |
| Antares Pharma, INC. | $105.43 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $77.99 | 2019-2020 | |
| Blue Earth Diagnostics | $61.99 | 2020-2021 | |
| Urogen Pharma, INC. | $49.67 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $36.11 | 2021 | |
| Rochester Medical Corporation | $26.86 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $21.59 | 2019 | |
| Boston Scientific Corporation | $19.33 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.07 | 2020 | |
| Neotract INC. | $17.48 | 2019 | |
| Dendreon Pharmaceuticals LLC | $17.30 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $17.03 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acerus Pharmaceuticals Corporation | $16.04 | 2021 | |
| Avadel Specialty Pharmaceuticals, LLC | $15.27 | 2019 | |
| Mission Pharmacal Company | $14.96 | 2019 | |
| Zyla Life Sciences, INC. | $13.33 | 2019 | |
| Pfizer INC. | $11.03 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Moreno listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.